Steigerwald, Gordon & Koch Inc. Ginkgo Bioworks Holdings, Inc. Transaction History
Steigerwald, Gordon & Koch Inc.
- $803 Million
- Q1 2024
A detailed history of Steigerwald, Gordon & Koch Inc. transactions in Ginkgo Bioworks Holdings, Inc. stock. As of the latest transaction made, Steigerwald, Gordon & Koch Inc. holds 10,000 shares of DNA stock, worth $3,300. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,000Holding current value
$3,300% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding DNA
# of Institutions
359Shares Held
1.26BCall Options Held
845KPut Options Held
2.54M-
Baillie Gifford & CO233MShares$76.9 Million0.21% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl190MShares$62.6 Million1.57% of portfolio
-
Viking Global Investors LP143MShares$47.2 Million0.63% of portfolio
-
Vanguard Group Inc Valley Forge, PA126MShares$41.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY72.9MShares$24 Million0.0% of portfolio
About Ginkgo Bioworks Holdings, Inc.
- Ticker DNA
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 1,287,779,968
- Market Cap $425M
- Description
- Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...